MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $572 | -67.3% | 13,139 | -72.8% | 0.00% | -63.6% |
| Q2 2023 | $1,747 | -50.5% | 48,353 | -49.1% | 0.01% | -56.0% |
| Q1 2023 | $3,529 | -18.4% | 94,912 | -0.6% | 0.02% | -24.2% |
| Q4 2022 | $4,327 | -99.9% | 95,495 | -0.0% | 0.03% | -35.3% |
| Q3 2022 | $6,672,000 | +81.2% | 95,535 | +74.2% | 0.05% | +88.9% |
| Q2 2022 | $3,682,000 | -18.3% | 54,842 | 0.0% | 0.03% | +3.8% |
| Q1 2022 | $4,509,000 | -44.6% | 54,842 | -0.0% | 0.03% | -38.1% |
| Q4 2021 | $8,133,000 | -15.7% | 54,869 | +0.6% | 0.04% | -20.8% |
| Q3 2021 | $9,648,000 | -11.7% | 54,535 | -19.4% | 0.05% | -20.9% |
| Q2 2021 | $10,925,000 | +619.7% | 67,633 | +663.4% | 0.07% | +570.0% |
| Q1 2021 | $1,518,000 | – | 8,859 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |